|
1
|
The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
|
Leukemia
|
2010
|
1.56
|
|
2
|
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
|
Leukemia
|
2005
|
1.39
|
|
3
|
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
|
Klin Padiatr
|
2005
|
1.32
|
|
4
|
Blood dyscrasias induced by psychotropic drugs.
|
Pharmacopsychiatry
|
2004
|
1.31
|
|
5
|
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
|
Leukemia
|
2005
|
1.14
|
|
6
|
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
|
Leukemia
|
2008
|
1.13
|
|
7
|
CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
|
Leukemia
|
2004
|
1.09
|
|
8
|
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
|
Leukemia
|
2009
|
1.07
|
|
9
|
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
|
Leukemia
|
2004
|
1.06
|
|
10
|
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.
|
Leukemia
|
2006
|
0.96
|
|
11
|
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
|
Leukemia
|
2008
|
0.95
|
|
12
|
Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature.
|
Ann Hematol
|
2003
|
0.94
|
|
13
|
Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases.
|
Leukemia
|
2006
|
0.90
|
|
14
|
CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
|
Leukemia
|
2011
|
0.90
|
|
15
|
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
|
Leukemia
|
2002
|
0.90
|
|
16
|
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
|
Leukemia
|
2007
|
0.88
|
|
17
|
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping.
|
Leukemia
|
2007
|
0.87
|
|
18
|
Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.
|
Leukemia
|
2004
|
0.86
|
|
19
|
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
|
Klin Padiatr
|
2013
|
0.86
|
|
20
|
Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
|
Cytometry B Clin Cytom
|
2006
|
0.83
|
|
21
|
[Accuracy of the sonographic determination of the splenic weight in comparison with the weight at autopsy].
|
Rofo
|
2003
|
0.83
|
|
22
|
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients.
|
Ann Oncol
|
2009
|
0.81
|
|
23
|
Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.
|
Leukemia
|
2010
|
0.81
|
|
24
|
Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
|
Klin Padiatr
|
2013
|
0.78
|
|
25
|
Clinical research and industrial sponsoring: avenues towards transparency and credibility.
|
Onkologie
|
2003
|
0.77
|
|
26
|
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
|
Ann Oncol
|
2006
|
0.77
|
|
27
|
The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.
|
Leukemia
|
2004
|
0.77
|
|
28
|
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
|
Med Pediatr Oncol
|
2002
|
0.77
|
|
29
|
[Aspects of acute palliative medical care in need of improvement].
|
HNO
|
2013
|
0.75
|
|
30
|
[Hematopoietic growth factors. Possibilities and limitations].
|
Internist (Berl)
|
2010
|
0.75
|